A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
- 1 December 2010
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 46 (18) , 3287-3293
- https://doi.org/10.1016/j.ejca.2010.07.005
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic TargetsJournal of Clinical Oncology, 2010
- Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietinJournal of Neurosurgery, 2007
- Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumorsJournal of Neurosurgery, 2007
- Outcome of children treated with preradiation chemotherapy for a high‐grade glioma: Results of a French Society of Pediatric Oncology (SFOP) pilot studyPediatric Blood & Cancer, 2006
- Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem gliomaCancer, 2006
- Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group StudyJournal of Clinical Oncology, 2005
- Determination of Gefitinib in Plasma by Liquid Chromatography with a C12 Column and Electrospray Tandem Mass Spectrometry DetectionJournal of Liquid Chromatography & Related Technologies, 2004
- Magnetic Resonance Scans Should Replace Biopsies for the Diagnosis of Diffuse Brain Stem GliomasNeurosurgery, 1993
- Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor functionBiochemical and Biophysical Research Communications, 1991
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985